1. Downregulation of CD147 by chitooligosaccharide inhibits MMP-2 expression and suppresses the metastatic potential of human gastric cancer
    ZHIGUO LUO et al, 2014, Oncology Letters CrossRef
  2. Antiproliferative Activity of Triterpene Glycoside Nutrient from Monk Fruit in Colorectal Cancer and Throat Cancer
    Can Liu et al, 2016, Nutrients CrossRef
  3. Genetic variations in the monocarboxylate transporter genes (SLC16A1, SLC16A3, and SLC16A11) in the Japanese population
    Yuki Kimura et al, 2018, Drug Metabolism and Pharmacokinetics CrossRef
  4. EMMPRIN expression is associated with metastatic progression in osteosarcoma
    Han-Soo Kim et al, 2021, BMC Cancer CrossRef
  5. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction
    Maksim Ionov et al, 2015, International Journal of Pharmaceutics CrossRef
  6. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
    Cory D. Bovenzi et al, 2015, BioMed Research International CrossRef
  7. Loss of CD147 results in impaired epithelial cell differentiation and malformation of the meibomian gland
    J Mauris et al, 2015, Cell Death & Disease CrossRef
  8. Downregulation of monocarboxylate transporter 1 inhibits the invasion and migration through suppression of the PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells
    Pei Zhang et al, 2018, Journal of Bioenergetics and Biomembranes CrossRef
  9. Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect
    Andreia Pereira-Nunes et al, 2020, Tumor Microenvironment CrossRef
  10. CD147 Promote Proliferation in Prostate Cancer Cell
    Qing Fang et al, 2014, Advanced Materials Research CrossRef
  11. Overexpression of CD147 is associated with poor prognosis, tumor cell migration and ERK signaling pathway activation in hepatocellular carcinoma
    Wenjing Xiao et al, 2017, Experimental and Therapeutic Medicine CrossRef
  12. Modulation of glucose metabolism through macrophage-membrane-coated metal-organic framework nanoparticles for triple-negative breast cancer therapy
    Qing Yao et al, 2024, Chemical Engineering Journal CrossRef
  13. EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2
    S Sangboonruang et al, 2014, Cancer Gene Therapy CrossRef
  14. RETRACTED: Physcion induces mitochondria-driven apoptosis in colorectal cancer cells via downregulating EMMPRIN
    Xuehong Chen et al, 2015, European Journal of Pharmacology CrossRef
  15. Novel regulators of spermatogenesis
    Kin Lam Fok et al, 2014, Seminars in Cell & Developmental Biology CrossRef
  16. Identification of the HT-29 cell line as a model for investigating MCT1 transporters in sigmoid colon adenocarcinoma
    Hashemeya Al-mousawi et al, 2020, Biochemical and Biophysical Research Communications CrossRef